E
Profound Medical Corp. PRN.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -41.12M -32.34M -28.20M -31.53M -27.73M
Total Depreciation and Amortization 739.00K 832.00K 919.00K 789.00K 853.00K
Total Amortization of Deferred Charges -91.00K -91.00K -91.00K 45.00K --
Total Other Non-Cash Items 2.64M 2.01M 1.83M 3.46M 3.64M
Change in Net Operating Assets 3.80M 3.09M 2.79M 2.79M 823.00K
Cash from Operations -34.03M -26.51M -22.75M -24.44M -22.42M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -1.48M -2.08M -2.42M -2.10M -1.62M
Issuance of Common Stock 39.21M 39.21M 62.15M 22.94M 22.95M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -3.04M -3.04M -4.90M -1.86M -1.86M
Cash from Financing 34.70M 34.10M 54.84M 18.99M 19.47M
Foreign Exchange rate Adjustments 450.00K -2.34M -3.39M -1.05M -2.25M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1.12M 5.25M 28.70M -6.50M -5.20M